PEC vs Intech Biopharm: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Intech Biopharm (6461) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Intech Biopharm

0%+2527%-100%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYIntech BiopharmYoY
Oct 2026NT$2.84 billion+102.0%NT$4,000-99.7%
Sep 2026NT$2.64 billion+100.0%NT$7.2 million+18.1%
Aug 2026NT$2.62 billion+105.4%NT$5.7 million+1,103.0%
Jul 2026NT$2.51 billion+92.6%NT$211,000-70.2%
Jun 2026NT$2.33 billion+94.9%NT$6.2 million-91.3%
May 2026NT$2.46 billion+108.5%NT$7.1 million-47.1%
Apr 2026NT$2.06 billion+68.3%NT$5.6 million+43.7%
Mar 2026NT$1.94 billion+64.4%NT$8.6 million+2,527.1%
Feb 2026NT$1.6 billion+56.7%NT$1.6 million-72.4%
Jan 2026NT$1.58 billion+49.8%NT$7.4 million+394.2%
Dec 2025NT$1.92 billion+69.9%NT$2.7 million-56.7%
Nov 2025NT$1.55 billion+53.0%NT$533,000-84.1%
Oct 2025NT$1.4 billion+53.6%NT$1.6 million+4.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16